| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -5.18M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MREO returned -82.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -30.5% |
| 1 year | -82.9% |
| 5 years | -89.6% |
| All-time high | $5.60 (Apr 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MREO would be worth today ›No. Mereo BioPharma Group plc has not paid a dividend in the past 12 months.
Mereo BioPharma Group plc stock trades on NASDAQ under the ticker symbol MREO.
Mereo BioPharma Group plc is part of the Healthcare sector.
Mereo BioPharma Group plc has a market cap of 46.37M USD, based on the latest quote.
Mereo BioPharma Group plc is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
